Evaluating interleukin-6 levels and the rs1800795 variant in Turkish patients with COVID-19: a prospective cohort study

References

• Ruan, Q.; Yang, K.; Wang, W.; Jiang, L.; Song, J. Clinical Predictors of Mortality Due to COVID-19 Based on an Analysis of Data of 150 Patients from Wuhan, China. Intensive Care Med. 2020, 46, 846–848. DOI: 10.1007/s00134-020-05991-x.
   PubMed Web of Science ®Google Scholar
• Prompetchara, E.; Ketloy, C.; Palaga, T. Immune Responses in COVID-19 and Potential Vaccines: Lessons Learned from SARS and MERS Epidemic. Asian Pac. J. Allergy Immunol. 2020, 38, 1–9.
   PubMed Web of Science ®Google Scholar
• Sun, X.; Wang, T.; Cai, D.; Hu, Z.; Chen, J.; Liao, H.; Zhi, L.; Wei, H.; Zhang, Z.; Qiu, Y.; et al. Cytokine Storm İntervention in the Early Stages of COVID-19 Pneumonia. Cytokine Growth Factor Rev. 2020, 53, 38–42. DOI: 10.1016/j.cytogfr.2020.04.002.
   PubMed Web of Science ®Google Scholar
• Walston, J. D.; Fallin, M. D.; Cushman, M.; Lange, L.; Psaty, B.; Jenny, N.; Browner, W.; Tracy, R.; Durda, P.; Reiner, A. IL-6 Gene Variation is Associated with IL-6 and C-Reactive Protein Levels but Not Cardiovascular Outcomes in the Cardiovascular Health Study. Hum. Genet. 2007, 122, 485–494. DOI: 10.1007/s00439-007-0428-x.
   PubMed Web of Science ®Google Scholar
• Rose-John, S.; Winthrop, K.; Calabrese, L. The Role of IL-6 in Host Defence against İnfections: İmmunobiology and Clinical İmplications. Nat. Rev. Rheumatol. 2017, 13, 399–409. DOI: 10.1038/nrrheum.2017.83.
   PubMed Web of Science ®Google Scholar
• Kuhn, III, C.; Homer, R. J.; Zhu, Z.; Ward, N.; Flavell, R. A.; Geba, G. P.; Elias, J.; A. Airway Hyperresponsiveness and Airway Obstruction in Transgenic Mice: Morphologic Correlates in Mice Overexpressing İnterleukin (IL)-11 and IL-6 in the Lung. Am. J. Respir. Cell Mol. Biol. 2000, 22, 289–295. DOI: 10.1165/ajrcmb.22.3.3690.
   PubMed Web of Science ®Google Scholar
• Swaroopa, D.; Bhaskar, K.; Mahathi, T.; Katkam, S.; Raju, Y. S.; Chandra, N.; Kutala, V. K. Association of Serum İnterleukin-6, İnterleukin-8, and Acute Physiology and Chronic Health Evaluation II Score with Clinical Outcome in Patients with Acute Respiratory Distress Syndrome. Indian J. Crit. Care Med. 2016, 20, 518–525. DOI: 10.4103/0972-5229.190369.
   PubMedGoogle Scholar
• Majello, B.; Arcone, R.; Toniatti, C.; Ciliberto, G. Constitutive and IL‐6‐İnduced Nuclear Factors That İnteract with the Human C‐Reactive Protein Promoter. Embo J. 1990, 9, 457–465. DOI: 10.1002/j.1460-2075.1990.tb08131.x.
   PubMed Web of Science ®Google Scholar
• Velazquez-Salinas, L.; Verdugo-Rodriguez, A.; Rodriguez, L. L.; Borca, M. V. The Role of İnterleukin 6 during Viral İnfections. Front. Microbiol. 2019, 10, 1057. DOI: 10.3389/fmicb.2019.01057.
   PubMed Web of Science ®Google Scholar
• Fishman, D.; Faulds, G.; Jeffery, R.; Mohamed-Ali, V.; Yudkin, J. S.; Humphries, S.; Woo, P. The Effect of Novel Polymorphisms in the İnterleukin-6 (IL-6) Gene on IL-6 Transcription and Plasma IL-6 Levels, and an Association with Systemic-Onset Juvenile Chronic Arthritis. J. Clin. Invest. 1998, 102, 1369–1376. DOI: 10.1172/JCI2629.
   PubMed Web of Science ®Google Scholar
• Ferrari, S.; Ahn-Luong, L.; Garnero, P.; Humphries, S.; Greenspan, S. Two Promoter Polymorphisms Regulating İnterleukin-6 Gene Expression Are Associated with Circulating Levels of C-Reactive Protein and Markers of Bone Resorption in Postmenopausal Women. J. Clin. Endocrinol. Metab. 2003, 88, 255–259. DOI: 10.1210/jc.2002-020092.
   PubMed Web of Science ®Google Scholar
• Tseng, L.-H.; Chen, P.-J.; Lin, M.-T.; Singleton, K.; Martin, E. G.; Yen, A.-H.; Martin, P. J.; Hansen, J. A. Simultaneous Genotyping of Single Nucleotide Polymorphisms in the IL-1 Gene Complex by Multiplex Polymerase Chain Reaction-Restriction Fragment Length Polymorphism. J. Immunol. Methods. 2002, 267, 151–156. DOI: 10.1016/s0022-1759(02)00165-5.
   PubMed Web of Science ®Google Scholar
• Gadient, R. A.; Patterson, P. H. Leukemia İnhibitory Factor, Interleukin 6, and Other Cytokines Using the GP130 Transducing Receptor: Roles in İnflammation and İnjury. Stem Cells 1999, 17, 127–137. DOI: 10.1002/stem.170127.
   PubMed Web of Science ®Google Scholar
• Wolf, J.; Rose-John, S.; Garbers, C. Interleukin-6 and İts Receptors: A Highly Regulated and Dynamic System. Cytokine 2014, 70, 11–20. DOI: 10.1016/j.cyto.2014.05.024.
   PubMed Web of Science ®Google Scholar
• Moore, J. B.; June, C. H. Cytokine Release Syndrome in Severe COVID-19. Science 2020, 368, 473–474. DOI: 10.1126/science.abb8925.
   PubMed Web of Science ®Google Scholar
• Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical Features of Patients İnfected with 2019 Novel Coronavirus in Wuhan, China. Lancet 2020, 395, 497–506. DOI: 10.1016/S0140-6736(20)30183-5.
   PubMed Web of Science ®Google Scholar
• Ponti, G.; Maccaferri, M.; Ruini, C.; Tomasi, A.; Ozben, T. Biomarkers Associated with COVID-19 Disease Progression. Crit. Rev. Clin. Lab. Sci. 2020, 57, 389–399. DOI: 10.1080/10408363.2020.1770685.
   PubMed Web of Science ®Google Scholar
• Sabaka, P.; Koščálová, A.; Straka, I.; Hodosy, J.; Lipták, R.; Kmotorková, B.; Kachlíková, M.; Kušnírová, A. Role of İnterleukin 6 as a Predictive Factor for a Severe Course of Covid-19: Retrospective Data Analysis of Patients from a Long-Term Care Facility during Covid-19 Outbreak. BMC Infect. Dis. 2021, 21, 308. DOI: 10.1186/s12879-021-05945-8.
   PubMed Web of Science ®Google Scholar
• Zeng, F.; Huang, Y.; Guo, Y.; Yin, M.; Chen, X.; Xiao, L.; Deng, G. Association of İnflammatory Markers with the Severity of COVID-19: A Meta-Analysis. Int. J. Infect. Dis. 2020, 96, 467–474. DOI: 10.1016/j.ijid.2020.05.055.
   PubMed Web of Science ®Google Scholar
• Tanaka, T.; Narazaki, M.; Kishimoto, T. Immunotherapeutic İmplications of IL-6 Blockade for Cytokine Storm. Immunotherapy 2016, 8, 959–970. DOI: 10.2217/imt-2016-0020.
   PubMed Web of Science ®Google Scholar
• Han, H.; Ma, Q.; Li, C.; Liu, R.; Zhao, L.; Wang, W.; Zhang, P.; Liu, X.; Gao, G.; Liu, F.; et al. Profiling Serum Cytokines in COVID-19 Patients Reveals IL-6 and IL-10 Are Disease Severity Predictors. Emerg. Microbes Infect. 2020, 9, 1123–1130. DOI: 10.1080/22221751.2020.1770129.
   PubMed Web of Science ®Google Scholar
• Zhang, J.; Hao, Y.; Ou, W.; Ming, F.; Liang, G.; Qian, Y.; Cai, Q.; Dong, S.; Hu, S.; Wang, W.; Wei, S. Serum İnterleukin-6 is an İndicator for Severity in 901 Patients with SARS-CoV-2 İnfection: A Cohort Study. J. Transl. Med. 2020, 18, 406. DOI: 10.1186/s12967-020-02571-x.
   PubMed Web of Science ®Google Scholar
• Jones, S. A.; Hunter, C. A. Is IL-6 a Key Cytokine Target for Therapy in COVID-19? Nat. Rev. Immunol. 2021, 21, 337–339. DOI: 10.1038/s41577-021-00553-8.
   PubMed Web of Science ®Google Scholar
• Tong, Y.; Wang, Z.; Geng, Y.; Liu, J.; Zhang, R.; Lin, Q.; Li, X.; Huang, D.; Gao, S.; Hu, D.; et al. The Association of Functional Polymorphisms of IL-6 Gene Promoter with İschemic Stroke: Analysis in Two Chinese Populations. Biochem. Biophys. Res. Commun. 2010, 391, 481–485. DOI: 10.1016/j.bbrc.2009.11.084.
   PubMed Web of Science ®Google Scholar
• Zidan, H. E.; Elbehedy, R. M.; Azab, S. F. IL6-174 G/C Gene Polymorphism and İts Relation to Serum IL6 in Egyptian Children with Community-Acquired Pneumonia. Cytokine 2014, 67, 60–64. DOI: 10.1016/j.cyto.2014.02.013.
   PubMed Web of Science ®Google Scholar
• Dou, L.; Yu, B.; Han, K.; Xiao, M.; Liu, Y.; Lv, F. Association of IL-6 Polymorphisms with Chronic Obstructive Pulmonary Disease Risk: Meta-Analysis of Genetic Association, Gene Expression and Expression Quantitative Trait Locus Analysis. Per. Med. 2016, 13, 395–403. DOI: 10.2217/pme-2016-0003.
   PubMed Web of Science ®Google Scholar
• García-Ramírez, R. A.; Ramírez-Venegas, A.; Quintana-Carrillo, R.; Camarena, Á. E.; Falfán-Valencia, R.; Mejía-Aranguré, J. M. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe İnfluenza A (H1N1) Virus İnfection in the Mexican Population. PLoS One. 2015, 10, e0144832. DOI: 10.1371/journal.pone.0144832.
   PubMed Web of Science ®Google Scholar
• Riazalhosseini, B.; Mohamed, Z.; Apalasamy, Y. D.; Shafie, N. S.; Mohamed, R. Interleukin-6 Gene Variants Are Associated with Reduced Risk of Chronicity in Hepatitis B Virus İnfection in a Malaysian Population. Biomed. Rep. 2018, 9, 213–220. DOI: 10.3892/br.2018.1126.
   PubMed Web of Science ®Google Scholar
• Kerget, F.; Kerget, B. Frequency of İnterleukin-6 rs1800795 (-174G/C) and rs1800797 (-597G/A) Polymorphisms in COVID-19 Patients in Turkey Who Develop Macrophage Activation Syndrome. Jpn. J. Infect. Dis. 2021, 74, 543–548. DOI: 10.7883/yoken.JJID.2021.046.
   PubMed Web of Science ®Google Scholar
• Kirtipal, N.; Bharadwaj, S. Interleukin 6 Polymorphisms as an İndicator of COVID-19 Severity in Humans. J. Biomol. Struct. Dyn. 2021, 39, 4563–4565. DOI: 10.1080/07391102.2020.1776640.
   PubMed Web of Science ®Google Scholar
• Karayel, A.; Özgültekin, A.; Yağcı, B.; Sari, A.; Balık, Y.; Aksaray, S.; Ekinci, O. Do IL-6 Levels and Other Inflammatory Parameters Correlate with the Lung Computed Tomography Involvement Scores in Critical COVID-19 Patients? Tybd. 2020, 18, 39–45. DOI: 10.4274/tybd.galenos.2020.96168.
   Google Scholar